Jane B. Allendorfer, PhD, University of Alabama at Birmingham, Birmingham, AL, explores the current standing of research regarding the benefits of exercise at a molecular and cellular level in patients with neurological disorders. While the benefits have been established in healthy patient populations, further research is needed to understand the molecular and cellular effects in patients with epilepsy and other neurological disorders. Brain-derived neurotrophic factor (BDNF) is a neurotransmitter currently under investigation, and while it has been established that there may be a positive correlation between BDNF levels and exercise, additional studies are still required. This is due to inconsistencies in research investigations and the novelty of exercise-related research in neurological disorders. This interview took place at the American Academy of Neurology 2022 Congress in Seattle, WA.
Dr Allendorfer reports the following disclosures:
Consulting for LivaNova Inc.